Darlene Dobkowski | Authors


Invasive GIST Originating in the Stomach/Small Intestine Is More Common in Men, Study Shows

February 19, 2021

Men appear to be more likely than women to have invasive gastrointestinal stromal tumors originating in the stomach and small intestines. For treatment, an expert says that combined surgery and systemic therapy demonstrates the best outcomes.

Venetoclax/Rituximab Shows 5-Year Survival Benefit in Relapsed/Refractory CLL

December 05, 2020

Sustained progression-free survival and overall survival benefit at 5 years were observed in patients with relapsed or refractory (R/R) chronic lymphocytic leukemia treated with the combination of venetoclax plus rituximab compared with bendamustine plus rituximab in the MURANO trial.